the aid library

LIST OPTIONS

Filter

5756

O papel dos agentes comunitários de saúde na vacinação contra a COVID-19: guia de apoio à implementaçao

Organização Mundial da Saúde (OMS); UNICEF (2021) C_WHO

The role of community health workers in the vaccination against COVID-19: guide to support the implementation of the vaccination programme

External Link

COVID-19 und Impfen

Robert-Koch-Institut RKI (2021) CC

Informationsseite des RKI rund um Impfen und COVID-19

External Link

COVID-19 vaccine introduction toolkit
recommended

World Health Organization WHO (2021) C_WHO

The COVID-19 vaccine introduction toolbox equips all countries to prepare for and implement COVID-19 vaccination by providing guidance, tools, and training. This toolbox is intended to support Ministries of Health, health workers, partner organizations, and other stakeholders.

Download (133)

View PDF (158)

Africa Joint Continental Strategy for COVID-19 Outbreak

African Union; Africa CDC Centres for Disease Control and Prevention (2020) C2

Accessed: 02.04.2020

Download (345)

View PDF (456)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

External Link

COVID-19 in Malawi: lessons in pandemic preparedness from a tertiary children’s hospital

Chaziya J, Freyne B, Lissauer S et al. (2021) CC

Archives of Disease in Childhood 2021;106:238-240.

Download (144)

View PDF (146)

Statement on the use of Dexamethasone for severely ill COVID-19 Patients

African Union; Africa CDC Centres for Disease Control and Prevention (2020) C1

Africa Centers for Disease Control and Prevention (Africa CDC) is aware of the media releases of the preliminary results of a large randomized clinical trial conducted in the United Kingdom, which included dexamethasone, a corticosteroid, as one of the drugs used for the treatment of COVID-19 patien... more

Download (159)

View PDF (202)

Recommendations to Member States to improve hand hygiene practices to help prevent the transmission of the COVID-19 virus: interim guidance (Chinese Version)

World Health Organization WHO (2020) C_WHO

就改进手卫生做法助力预防COVID-19病毒传播给会员国的建议

External Link

COVID-19 and HIV

Centers for Disease Control and Prevention CDC (2021) C_CDC

Resource Page for People At Risk For or With HIV and for Clinicians

Download (175)

View PDF (221)

Banso Tolonga – COVID-19 Rumor Tracking Bulletin

Internews (2021) CC

The project aims to build trust around COVID-19 vaccines to ensure greater access to and uptake in the vaccines through establishing healthy information ecosystems to address mis- and disinformation and vaccine hesitancy in the Democratic Republic of Congo (DRC). The bulletins are in French.

Download (143)

View PDF (187)

Guidance on Environmental decontamination in the context of COVID-19 - Arabic Verion

Africa CDC Centres for Disease Control and Prevention; African Union (2020) C1

]. تختلف مخاطر التلوث COVID-19المادية في سياق جائحة مرض فيروس كـــورونـا المستجد [السطحي وانتقال العدوى باختلاف نوع الإعداد وحجم السكان الذين يترددون على كل مكان (مثل: م�... more

External Link

Covid-19 Online Courses for CHAI Hospitals
recommended

Catholic Health Association of India CHAI (2020) CC

CHAI Academy is an initiative of CHAI in collaboration with Tech Care for All (TC4A). In the context of the COVID 19 crisis, CHAI Academy is rolling out 4 online courses: 1. Hospital Directors, Administrators and management team (7 Hrs) 2. Nurses and allied healthcare providers (6 Hrs) 3. Doct... more

Download (163)

View PDF (205)

Alcohol and COVID-19: what you need to know (Arabic)

World Health Organization WHO; Regional Office for the Eastern Mediterreanan (2020) C_WHO

Facing the COVID-19 (new coronavirus disease) pandemic, the countries of the world must take decisive action to stop the spread of the virus. In these critical circumstances, it is es- sential that everyone is informed about other health risks and hazards so that they can stay safe and healthy. The... more

Download (128)

View PDF (148)

Остановить распространение теорий заговора о COVID-19

UNESCO UNESCO (2020) C1

Новая кампания поможет вам научиться распознавать, раскрывать, реагировать и сообщать о теориях заговора, чтобы предотвратить их распространение. Критическое мыш... more

Download (206)

View PDF (162)

COVID-19 & Community Health Workers (Arabic Version)
recommended

African Union; Africa CDC Centres for Disease Control and Prevention (2021) CC

2-Day Orientation training Orientation Training, 1 Febr. 2021 Community Health Workers (CHWs) are an essential part of the Partnership to Accelerate COVID-19 Testing (PACT) Initiative • Africa CDC set up PACT to drive forward the Africa Union Joint Continental Strategy for COVID-19 Available in ... more